Protalix BioTherapeutics (PLX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 3.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.09% |
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 0.33% |
| Jun 30, 2025 | -0.15% |
| Mar 31, 2025 | -1.16% |
| Dec 31, 2024 | -2.56% |
| Sep 30, 2024 | -2.82% |
| Jun 30, 2024 | -2.62% |
| Mar 31, 2024 | -0.33% |
| Dec 31, 2023 | 0.87% |
| Sep 30, 2023 | 0.32% |
| Jun 30, 2023 | -1.10% |
| Mar 31, 2023 | -2.09% |
| Dec 31, 2022 | -4.78% |
| Sep 30, 2022 | -5.68% |
| Jun 30, 2022 | -6.94% |
| Mar 31, 2022 | -6.87% |
| Dec 31, 2021 | -8.09% |
| Sep 30, 2021 | -8.57% |
| Jun 30, 2021 | -10.41% |
| Mar 31, 2021 | -12.92% |
| Dec 31, 2020 | -14.22% |
| Sep 30, 2020 | -16.56% |
| Jun 30, 2020 | -16.25% |
| Mar 31, 2020 | -16.05% |
| Dec 31, 2019 | -15.38% |
| Sep 30, 2019 | -15.20% |
| Jun 30, 2019 | -14.54% |
| Mar 31, 2019 | -13.35% |
| Dec 31, 2018 | -13.12% |
| Dec 31, 2017 | -12.05% |
| Mar 31, 2017 | -13.52% |
| Dec 31, 2016 | -14.06% |
| Sep 30, 2016 | -13.94% |
| Jun 30, 2016 | -14.19% |
| Mar 31, 2016 | -16.00% |
| Dec 31, 2015 | -15.78% |
| Dec 31, 2014 | -14.85% |
| Dec 31, 2013 | -7.73% |